Physician profile
David G Jaskey
NPI 1003843582
$742.53
in general payments reported to CMS, 2019-2025
17 companies · $32.41 in 2025
The $32.41 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2020: $77.05 · 2021: $127 · 2022: $158 · 2023: $168 · 2024: $33.36 · 2025: $32.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $233.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $228.89 | 2022-2025 | Freestyle Libre 3 |
| Becton, Dickinson and Company | $120.93 | 2019 | |
| Amgen INC. | $116.99 | 2020-2023 | Evenity, Prolia |
| Abbvie INC. | $46.48 | 2019-2023 | |
| Nestle Healthcare Nutrition INC. | $40.00 | 2021-2022 | |
| Mylan Pharmaceuticals INC. | $29.84 | 2022 | |
| Novo Nordisk INC | $29.40 | 2020 | |
| Dexcom, INC. | $17.20 | 2023 | Dexcom G6 Transmitter |
| Pfizer INC. | $17.11 | 2023 | |
| Esperion Therapeutics, INC. | $15.96 | 2023 | Nexletol |
| Pacira Therapeutics, INC. | $14.56 | 2021 | |
| Amarin Pharma, INC. | $14.46 | 2021 | |
| Merck Sharp & Dohme LLC | $12.36 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.26 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $11.79 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $10.89 | 2019 | |
| Kinex Medical Company LLC | $3.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Jaskey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.